Cortex – Life Sciences Insights

28 Apr, 2022

What FDA Expects From Medical Device Cybersecurity Efforts

By Jae Kim Raymond M. Williams

This article was first published in Law360 In recent years, the threat of cybersecurity attacks has evolved in the minds of the public...

25 Apr, 2022

By Amelia Prawda Jolanta Dabrowicz

On 7 April 2022, the Parliament passed the Act of 7 April 2022 on Medical Devices (the "Act"). It was signed by the President on 20...

20 Apr, 2022

By Emilio Ragosa

In this episode, DLA Piper managing partner Emilio Ragosa is joined by Kevin Sheridan, Joint Global Head of Healthcare Investment Banking...

19 Apr, 2022

By Andrea Fernandez Paula Gonzalez de Castejón Llano-Ponte

The annual report "Indicators of Access to Innovative Therapies in Europe (W.A.I.T. Indicator)", prepared by the consultancy firm Iqvia...

08 Apr, 2022

By Mariana Ricardo Ana Rita Santos

Both the Clinical Trials Coordination Group (CTCG) and the Portuguese National Authority of Medicines and Health Products (INFARMED) have...

06 Apr, 2022

By Amelia Prawda Jolanta Dabrowicz

On 29 March 2022, the Polish President signed the Act of 24 March 2022 amending the Act on Counteracting Drug Addiction (the "Act"). The...

05 Apr, 2022

By Elisa Lorenzo

After the publication of the Code of conduct regulating the processing of personal data in the field of clinical trials and other...

04 Apr, 2022

By Taryn Jones Teresa Hitchcock

The Medicines & Healthcare products Regulatory Agency (MHRA) has announced a new supervisory scheme as part of its process for monitoring...